Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1479-5876
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated ; volume:18 ; number:1 ; day:11 ; month:5 ; year:2020 ; pages:1-9 ; date:12.2020
Journal of translational medicine ; 18, Heft 1 (11.5.2020), 1-9, 12.2020

Urheber
Al Hashmi, Muna
Sastry, Konduru S.
Silcock, Lee
Chouchane, Lotfi
Mattei, Valentina
James, Nicola
Mathew, Rebecca
Bedognetti, Davide
De Giorgi, Valeria
Murtas, Daniela
Liu, Wei
Chouchane, Aouatef
Temanni, Ramzi
Seliger, Barbara
Wang, Ena
Marincola, Francesco M.
Tomei, Sara
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12967-020-02350-8
URN
urn:nbn:de:101:1-2020071707551308458166
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:47 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Al Hashmi, Muna
  • Sastry, Konduru S.
  • Silcock, Lee
  • Chouchane, Lotfi
  • Mattei, Valentina
  • James, Nicola
  • Mathew, Rebecca
  • Bedognetti, Davide
  • De Giorgi, Valeria
  • Murtas, Daniela
  • Liu, Wei
  • Chouchane, Aouatef
  • Temanni, Ramzi
  • Seliger, Barbara
  • Wang, Ena
  • Marincola, Francesco M.
  • Tomei, Sara
  • SpringerLink (Online service)

Ähnliche Objekte (12)

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

RNA amplification for successful gene profiling analysis

RNA amplification for successful gene profiling analysis

Translational medicine from observation to hypothesis to interpretation

Translational medicine from observation to hypothesis to interpretation

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma

BRAF V600E -mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism

BRAF V600E -mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism

Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease

Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease

Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report

Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report

Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option

Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option

Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report

Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report

Changing paradigm through a genome-based approach to clinical and basic immunology

Changing paradigm through a genome-based approach to clinical and basic immunology

Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling

Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling

Verbundene Objekte